This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
As 2023 comes to an end, in line with our annual tradition, we take stock of the top IP developments that occurred this year. We have also included a list of other notable IP developments of 2023. The judgement was passed in October 2022, but was uploaded in September 2023 on the High Court’s website. A special thanks to Mr. G.
The UPCKat trying to keep confidential information confidential in the UPC As part of our UPCKat reporting on the latest UPC developments, the IPKat brings readers a roundup of how the UPC is treating confidentiality and third party access to court documents.
Deepak Gupta & Ors Do trade secrets/confidential information need to have economic or commercial value? The impugned order, which referred to Section 21 of the Patents Act, was contended as an improper refusal under Section 15, as the petitioner had not received a second examination report and had not been given a chance to respond.
This week, the UK supreme court finally rejected the appeal by Dr Thaler to have DABUS named as an inventor on a patentapplication. 25 sequence listing added to the pages of a divisional has now been issued ( OJ EPO 2023, A98 ). 26: Is it time for patent offices to enter the bioinformatic age? Looking beyond ST.26:
A quick glance at last week – Madras HC accepts a US District Court’s Letter Rogatory to furnish confidential information, a look at Functional Fallacies in Thomson Reuters vs Ross Intelligence and many more. Interestingly, Judge Bibas has changed his position from his initial 2023 opinion in the same case.
As 2023 commences, it’s time for companies to review and take stock of their intellectual property assets. Such inventions may be protectable under federal patent laws. An inventor must secure a patentapplication within a very short period of time to prevent the work from falling into the public domain.
Softgel: The Errors of Comity The Madras High Court accepted a Letter Rogatory from The US District Court in Delaware directing India-based Softgel Healthcare to furnish confidential information to the US Court. Interestingly, Judge Bibas has changed his position from his initial 2023 opinion in the same case.
Here is our recap of last week’s top IP developments including summaries of the posts on IPO’s patentapplication rejection of HIV drug Dolutegravir, another judgement in the long-running Section 3(k) saga, this time on the patentability of business methods and the DHC IPD’s Annual Report 2023-24. Read more on this!
In yet another order dealing with unreasoned rejections of a patentapplication, the Delhi High Court comes down heavily on the Indian Patent Office. Praharsh and Swaraj write about this order, underscoring the role played by well-reasoned orders in the appeals before the high court and patent bargain.
But it’s now evident that AI is capable of producing inventions on its own, and there have been multiple documented instances of patentapplications where the person applying for a patent has recognized AI as the inventor. 8] Lisa Vertisky, Thinking Machines and Patent Law in Barfield et al (eds.),
Highlights Of The Week IPO Rejects Janssen’s Secondary PatentApplication for the Fumarate Salt form of Bedaquiline Image from here. Calcutta High Court observes that when an application has been rectified in conformity with the recommendation of the Controller, it is fair to assume that such an application will be allowed.
Kaijet highlights the narrowness of the pre-filing grace period (safe harbor) provision under the America Invents Act (AIA) and serves as a reminder that there are a number of patents that would have been valid under the pre-AIA patent system may no longer be valid under the current law. 2023-1336 (Fed. Sanho Corp.
Nirtech – Analysing the Claim of Breach of Confidential Information Image from here. Ex-employees using confidential information acquired from the former employer! Nirtech on protecting confidential information. on 19 April, 2023 (Delhi District Court) image from here. on 21 April, 2023 (Delhi High Court) Image from here.
The district court denied the motion to dismiss four of the five, essentially holding Xcential had plead plausible facts that Akin Gump had misappropriated Xcential’s confidential information for the firm’s own benefit. The order is here. Pure Hemp Collective Inc. 22-01363 (Fed.
As 2023 commences, it’s time for companies to review and take stock of their intellectual property assets. Such inventions may be protectable under federal patent laws. An inventor must secure a patentapplication within a very short period of time to prevent the work from falling into the public domain.
The latter, contrary to what it might appear from its date of adoption (2014), is a regulation that is certainly topical, having started to take effect as of 31 July 2022, with a transitional period that will last until 31 January 2025, but which will see a first and fundamental provision entering into force on 31 January 2023.
However, the data was shared without confidentiality obligations and might be used for future training, so it could be considered public. Feeling a bit nervous because you submitted code snippets or asked ChatGPT to rewrite a patentapplication background section? enablement). Thankfully, the U.S.
However, the data was shared without confidentiality obligations and might be used for future training, so it could be considered public. Feeling a bit nervous because you submitted code snippets or asked ChatGPT to rewrite a patentapplication background section? enablement). Thankfully, the U.S.
Also, the Government has recently made an Amendment to the Patent Rule i.e. Indian Patent (Amendment) Rules, 2024 which aims to rationalize the patentapplication process and reduce the burden of the compilation and accelerate actions. Trade Secrets. References.
Discussing the Recent PatentApplication Restorations by Delhi and Madras High Courts. We discussed the recent orders from Delhi and Madras High Court regarding restoration of ‘deemed abandoned’ patentapplications. The last date to send the entries is January 2, 2023. Image from here. Never Gonna Give You Up?
However, the data was shared without confidentiality obligations and might be used for future training, so it could be considered public. Feeling a bit nervous because you submitted code snippets or asked ChatGPT to rewrite a patentapplication background section? enablement). Thankfully, the U.S.
Do You Need Multiple Patents for a Single, Multi-Use Invention? If your invention has multiple innovations or components, you may be wondering whether to file separate patentapplications for each innovation or file one application for the entire invention. thegem-vc-text.thegem-custom-640c2caad0b893792{display: block!
From conflicting positions on AI as a co-author of a work to the contours of information required u/s 39 about the patentapplications filed abroad, we had some engaging posts on this blog this week. 1253/DEL/2006 and 4197/DEL/2015) related to computer software based on earlier guidelines of the patent office. M/S Loreal S.A
Highlights of the Week India Accelerates in the Patent Race: But Is There a Pot of Gold at the End of the Rainbow? Image from here The World IP Indicator 2023 highlights India’s progress in the global patent race. Please drop a comment and let us know. But does this guarantee innovation? Viridian Development Managers Pvt.
Applications are on a rolling basis and applicants interested to work and discuss transparency and accountability issues in the Indian IP ecosystem can apply. There is no deadline for the applications and the posts will be open till they are filled. Ericsson and Apple end patent-related legal row with licence deal.
The USPTO begins with a review of the duties of candor and good faith, confidentiality, and export regulations. AI contributions to a patentapplication may become problematic when such contributions are significant enough to be considered material to patentability and/or inventorship. July 7, 2023). [2]
The Court sets aside the rejection, staying the suit until the rectification application’s disposal within eight months. Ynsect vs The Controller Of Patents on 28 February, 2024 (Delhi High Court) Image from here The appeal challenged the denial of an Indian patentapplication for insect treatment.
Section 3 of the Patents Act lists statutorily non-patentable inventions, which pose a challenge to patentability depending on the subject matter claimed. In summary, a patentapplication for a medical device in India is often objected to under Sections 3(i), (f), and (k). 3] (1979) 2 SCC 511. [4] 7] 569 U.S.
The defendants also challenged the confidentiality of the information because it was shared with customers who didn’t sign NDAs. Late to discover that a former employee may have used your trade secrets in a patentapplication? District Court for Delaware. In Illumina Inc v Guardant Health, et al.,
District Court for the Southern District of Ohio Judge Timothy Black rejected arguments that a state court declaratory relief action over the ownership of several disputed patentapplications involved federal patent or trade secret claims and ruled that it belonged in state court. 21-cv-9321, 2023 WL 2051739 (S.D.N.Y.
By January 2023, the government triumphantly announced that its funding resulted in the development offour indigenous COVID vaccines in partnership with the private sector. In 2023, it became known that Bharat Biotech had filed a patentapplication for Covaxin in its own name back in 2020. 205 per dose.
Maharaja decision of 2023 (which the Court relied on in the present case to justify the damages) that damages are to be calculated on reasonable/ fair basis. At the same time, the Rules also curtail the requirement of disclosing working requirements of patents in India, crucial to Compulsory Licensing applications and interim injunctions.
We organize all of the trending information in your field so you don't have to. Join 9,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content